Kawaguchi, Japan

Keiko Watanabe

This inventor holds 1 USPTO granted patent. Top assignees: Nippon Kayaku Kabushiki Kaisha, Takara Shuzo Co., Inc.. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiko Watanabe. Retrieved from https://idiyas.com/inventor/keiko-watanabe-ojtns7h2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiko Watanabe: Inventor in Immunopotentiator Research

Introduction

Keiko Watanabe is a woman inventor associated with Kawaguchi, Japan. Her recorded patent concerns a spergualin-related compound and its use in preparing an immunopotentiator.

Latest Patents

Watanabe is associated with 1 patent: “Immunopotentiator and Spergualin-Related Compound Therefor.” The invention describes using a spergualin-related compound, or a pharmacologically acceptable salt of that compound, to prepare an immunopotentiator. The patent’s general formula defines chemical variations, including specified forms of X and options for Y, such as hydrogen, hydroxyl, or hydroxymethyl.

Career Highlights

The available information associates Watanabe with Takara Shuzo Co., Inc. and Nippon Kayaku Kabushiki Kaisha. Her patent reflects work involving compounds intended for immunopotentiator preparation.

Collaborations

Watanabe’s listed coworkers include Takeji Sakasai and Tsugio Tomiyoshi.

Conclusion

Keiko Watanabe’s recorded patent documents an immunopotentiator-related invention based on a spergualin-related compound and connects her work with two Japanese companies and named collaborators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…